PICC Line Removal – Evidence‑Based Recommendations

Indications for Removal

• Remove a PICC when it has not been used for any clinical purpose for ≥ 48 hours. 1
• Remove a PICC when the original therapeutic indication is fulfilled (e.g., completion of an antibiotic course). 1
• Remove a PICC that is used only for phlebotomy in a hemodynamically stable patient with adequate peripheral veins. 1
• Remove a PICC when there is confirmed line‑related bloodstream infection with objective bacteremia evidence. 2

PICC‑Related Deep Vein Thrombosis (DVT) – Specific Removal Criteria

• Remove the PICC if symptoms of venous occlusion (arm pain, swelling) persist despite ≥ 72 hours of therapeutic anticoagulation. 3
• Do not remove the PICC when irritant or vesicant infusions remain necessary. 3
• Do not remove the PICC when poor peripheral venous access exists and frequent phlebotomy is required. 4
• Do not remove the PICC if only ≤ 72 hours of anticoagulation have been provided and symptom improvement is minimal. 3

Removal Technique

Pre‑Removal Preparation

• Position the patient supine with the exit site below heart level to minimize air‑embolism risk. 5
• Extend the arm to facilitate safe catheter removal. 5
• Use chlorhexidine‑alcohol solution for skin antisepsis. 5
• Remove any stabilization devices (e.g., Statlock) securing the catheter. 5

Removal Procedure

• Wear sterile gloves and maintain aseptic technique throughout the procedure. 5
• Clean the exit site with antiseptic solution and allow it to dry completely before manipulation. 5
• Apply gentle, steady traction; avoid excessive force that could cause catheter breakage. 5
• If the catheter cannot be removed with gentle traction, consult vascular surgery or interventional radiology for assistance. 5

Post‑Removal Care

• Inspect the catheter to confirm it is intact and complete. 5
• Apply firm digital pressure for at least 5 minutes (or longer if needed) until hemostasis is achieved. 5
• Place a sterile occlusive dressing over the exit site to protect against infection. 5
• If bleeding persists, a skin stitch may be required. 5
• Document the procedure, including exit‑site condition and catheter integrity. 5

Special Considerations

• Anticoagulation is not a contraindication to PICC removal; standard hemostasis (firm pressure ≥ 5 minutes) is sufficient. 3
• The MAGIC guidelines endorse removal of a PICC in patients on therapeutic anticoagulation for PICC‑related DVT when specific criteria are met. 5
• Never advance a migrated PICC back into position; this practice is rated inappropriate. 4
• For a migrated PICC without infection, a guidewire exchange is the appropriate management. 4
• If infection is suspected or confirmed, the catheter should be removed. 4
• When catheter‑related infection is suspected, obtain appropriate cultures before removal to guide antibiotic therapy. 5
• Removal in the absence of confirmatory infection evidence is considered uncertain and should be based on clinical judgment regarding pathogen, bacteremia intensity, and patient stability. 1

Critical Pitfalls to Avoid

• Do not allow removal by clinicians trained only in central venous catheter (CVC) removal but not specifically in PICC removal; this is deemed inappropriate. 1
• Never forcefully pull a PICC if resistance is encountered; instead, consult interventional radiology or vascular surgery. 5
• Never advance a dislodged PICC; perform a guidewire exchange if no infection is present. 4
• Physician notification and order are required before PICC removal; removal without a physician order is prohibited. 1

Guidelines for Managing PICC Lines in Suspected Proximal Brachial Vein DVT

General Recommendation

• Functional peripherally inserted central catheters (PICCs) should not be routinely removed when a proximal brachial vein deep‑vein thrombosis (DVT) is suspected or confirmed, unless specific clinical criteria are satisfied. 6

Indications for PICC Removal

• Removal is indicated if any of the following conditions are present:
  
  • The PICC is no longer clinically necessary for patient care. 6
  • The PICC is used solely for phlebotomy and adequate peripheral veins are available. 6
  • Persistent symptoms of venous occlusion (e.g., arm pain, swelling) continue despite ≥ 72 hours of therapeutic anticoagulation. 6
  • A confirmed line‑related bloodstream infection with objective bacteremia evidence is present. 6

Contraindications to PICC Removal

• Do NOT remove the PICC if any of the following apply:
  
  • Ongoing administration of irritant or vesicant infusions that require the catheter. 6
  • Poor peripheral venous access combined with a need for frequent phlebotomy that would necessitate placement of a new PICC. 6
  • < 72 hours of therapeutic anticoagulation have been provided, even if symptoms show minimal improvement. 6

Situations Requiring Clinical Judgment

• Consider retaining the PICC when the patient cannot receive systemic anticoagulation but the line remains clinically necessary. 6
• When a line‑related infection is suspected but not yet confirmed, individualized judgment is required. 6

Management When PICC Remains In Situ

• Therapeutic anticoagulation for at least 3 months is the standard of care for PICC‑related DVT, regardless of whether the catheter is removed; shorter courses are deemed inappropriate. 6

Anticoagulation Details

• Warfarin therapy should target an INR of 2–3. 6
• In patients with active cancer, low‑molecular‑weight heparin (LMWH) is preferred over warfarin. 6

Urgent Intervention

• Immediate referral to interventional radiology is warranted when venous occlusion symptoms are accompanied by phlegmasia cerulea dolens (marked swelling, pain, and purplish discoloration of the limb). 6

Common Pitfalls to Avoid

• Do not remove a functional PICC prematurely (i.e., before 72 hours of anticoagulation) if vesicant infusions are still being administered. 6
• Do not rely on catheter removal alone as definitive therapy for DVT when anticoagulation is not contraindicated; this practice is considered inappropriate. 6
• Avoid placing a new PICC within 30 days of a PICC‑related DVT due to a high risk of recurrent thrombosis. 6